As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
In Collaboration with
IBD Expert Panel: When is the Right Time to Refer to GI?
IBD Expert Panel: When is the Right Time to Refer to GI?
Travel for IBD Patients: How to Help Them Prepare
Travel for IBD Patients: How to Help Them Prepare
IBD & Intimacy: Managing an Under-Recognized Issue
IBD & Intimacy: Managing an Under-Recognized Issue
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance
Managing IBD: A Patient's Perspective
Managing IBD: A Patient's Perspective
RISK Cohort Study in Crohn's Disease
RISK Cohort Study in Crohn's Disease
Improving Care for Children with IBD
Improving Care for Children with IBD
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Growing Up With IBD: When to Transition to an Adult GI Specialist
Growing Up With IBD: When to Transition to an Adult GI Specialist
Managing IBD as an Athlete: An NBA Pro's Perspective
Managing IBD as an Athlete: An NBA Pro's Perspective
Surgical Management of Crohn's Disease & Ulcerative Colitis
Surgical Management of Crohn's Disease & Ulcerative Colitis
Gut Feeling: The Links Between IBD and Mental Health
Gut Feeling: The Links Between IBD and Mental Health
Fecal Transplants: The Future of IBD Therapy?
Fecal Transplants: The Future of IBD Therapy?
The Crohn's & Colitis Foundation's New Clinical Trial Community
The Crohn's & Colitis Foundation's New Clinical Trial Community
Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
